StockNews.com Upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to Buy

StockNews.com upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a hold rating to a buy rating in a report issued on Monday morning. A number of other analysts have also commented on the stock. BMO Capital Markets restated an outperform rating and set a $234.00 price target on shares of Alnylam Pharmaceuticals in […]

Related Keywords

Canada ,William Blair ,Nasdaq ,Allspring Global Investments Holdings ,Investment Management ,Alnylam Pharmaceuticals Inc ,Analyst Recommendations For Alnylam Pharmaceuticals ,Alnylam Pharmaceuticals ,Hedge Funds Weigh In On Alnylam Pharmaceuticals ,Royal Bank ,Alnylam Pharmaceuticals Stock ,Quent Capital ,Needham Company ,News Ratings For Alnylam Pharmaceuticals Daily ,Free Report ,Moderate Buy ,Get Free Report ,Global Investments Holdings ,Alnylam Pharmaceuticals Daily ,